OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.180
+0.010 (0.85%)
Mar 6, 2026, 4:00 PM EST - Market closed
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.03, with a low estimate of 1.50 and a high estimate of 3.00. The average target predicts an increase of 72.03% from the current stock price of 1.18.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OPKO Health stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $2.25 → $1.5 | Buy | Maintains | $2.25 → $1.5 | +27.12% | Mar 2, 2026 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 20, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $2 → $1.6 | Strong Buy → Hold | Downgrades | $2 → $1.6 | +35.59% | Oct 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +90.68% | Oct 30, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +90.68% | May 1, 2025 |
Financial Forecast
Revenue This Year
586.78M
from 606.88M
Decreased by -3.31%
Revenue Next Year
638.15M
from 586.78M
Increased by 8.75%
EPS This Year
-0.26
from -0.30
EPS Next Year
-0.14
from -0.26
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 680.4M | 700.4M | |||
| Avg | 586.8M | 638.2M | |||
| Low | 524.3M | 598.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.1% | 19.4% | |||
| Avg | -3.3% | 8.8% | |||
| Low | -13.6% | 2.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.14 | -0.07 |
| Avg | -0.26 | -0.14 |
| Low | -0.40 | -0.25 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.